(Q34982571)

5 August 2017

1 reference

title

New directions in the development of antidepressants: the interface of neurobiology and psychiatry (English)

1 reference

5 August 2017

0 references

Charles B Nemeroff

1

1 reference

5 August 2017

1 June 2002

1 reference

5 August 2017

Human Psychopharmacology

1 reference

5 August 2017

17 Suppl 1

1 reference

5 August 2017

S13-6

1 reference

The dexamethasone suppression test in the clinical setting

5 August 2017

1 reference

Cerebrospinal fluid correlates of depression in Huntington's disease

21 January 2018

1 reference

DST studies in psychotic depression: a meta-analysis

21 January 2018

1 reference

CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia

21 January 2018

1 reference

Elevated CSF CRF in suicide victims

21 January 2018

1 reference

7 January 2021

Hypothalamic-pituitary-adrenal axis and suicide

1 reference

7 January 2021

Cerebrospinal fluid neuropeptides in mood disorder and dementia

1 reference

7 January 2021

CSF corticotropin-releasing hormone and somatostatin in major depression: response to antidepressant treatment and relapse

1 reference

7 January 2021

Rapid reversal of psychotic depression using mifepristone

1 reference

7 January 2021

Corticotrophin-releasing factor receptors: from molecular biology to drug design

1 reference

7 January 2021

Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses?

1 reference

7 January 2021

CSF corticotropin-releasing factor-like immunoactivity in chronic pain patients with and without major depression

1 reference

7 January 2021

Fluvoxamine alone in the treatment of delusional depression

1 reference

7 January 2021

Neuropeptide concentrations in the cerebrospinal fluid of depressed patients treated with electroconvulsive therapy. Corticotrophin-releasing factor, beta-endorphin and somatostatin

1 reference

7 January 2021

Elevated Concentrations of CSF Corticotropin-Releasing Factor-Like Immunoreactivity in Depressed Patients

1 reference

7 January 2021

A corticosteroid/dopamine hypothesis for psychotic depression and related states

1 reference

7 January 2021

Characterization of a 41-Residue Ovine Hypothalamic Peptide That Stimulates Secretion of Corticotropin and β-Endorphin

1 reference

7 January 2021

Rapid reversal of acute psychosis in the Cushing syndrome with the cortisol-receptor antagonist mifepristone (RU 486)

1 reference

7 January 2021

Effect of desipramine on cerebrospinal fluid concentrations of corticotropin-releasing factor in human subjects.

1 reference

7 January 2021

Long-term treatment of psychotic (delusional) depression with fluvoxamine: an open pilot study

1 reference

7 January 2021

Identifiers

DOI

10.1002/HUP.396

1 reference

5 August 2017

1 reference

PubMed ID

12404664